Health TrialsbyHealthPanel

Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure

ConditionsAgingWrinkle Appearance
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-65
SponsorAmazentis SA

About this trial

The aim of this study is to investigate the impact of a topical product on skin health and aging

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Written Informed Consent to participate in the study

Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.0112.

Willingness to actively participate in the study and to come to the scheduled visits

Female

Disqualifiers

Female participants: Pregnancy or lactation

Drug addicts, alcoholics

AIDS, HIV-positive or infectious hepatitis

Conditions which exclude a participation or might influence the test reaction/evaluation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Skin care product

    Other intervention

    The cosmetic skin care product will be applied twice daily to half of the face

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Cosmetic routineExperimental treatment 1 intervention
Group B: Untreated controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Skin hydration

Change from baseline in skin hydration (assessed on skin capacitance by Corneometer) after 2 and 8 weeks

Time frame
8 weeks

Secondary outcomes

1

Anti-wrinkle efficacy

Change from baseline in anti-wrinkles efficacy (assessed on three-dimensional structure of the wrinkles in the periorbital regions) after 2 and 8 weeks. Anti-wrinkle efficacy will be assessed using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

Time frame
8 weeks
2

Skin barrier function

Change from baseline in skin barrier function (assessed onTransepidermal water loss (TEWL) by Tewameter \[g/(m²h)\]) after 2 and 8 weeks

Time frame
8 weeks
3

Skin firmness

Change from baseline in skin firmness (assessed by R0 (Uf) by Cutometer \[mm\]) after 2 and 8 weeks

Time frame
8 weeks
4

Skin elasticity

Change from baseline in skin elasticity (assessed by R7 (Ur/Uf) by Cutometer) after 2 and 8 weeks

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Amazentis SA

Lead sponsor

SGS proderm GmbH

Collaborator

Source ClinicalTrials.gov
Apply now